Can B Corp. engages in the business of promoting health and wellness through developing, manufacturing, and selling products containing cannabinoids derived from hemp biomass, and the licensing of durable medical devices. The company is headquartered in Hicksville, New York and currently employs 12 full-time employees. The company went IPO on 2011-03-11. The firm is engaged in developing, manufacturing, and selling products containing cannabinoids derived from hemp biomass and the licensing of durable medical devices. Its products include oils, creams, moisturizers, isolates, gel caps, spa products, and concentrates and lifestyle products. The company develops its own line of proprietary products, as well as seeks synergistic value through acquisitions in the hemp industry. Its Duramed Division provides a sam Pro 2.0 medical device to patients through a doctor program whereby the physician evaluates the patients' needs for medical necessity, and if determined that the device use would be beneficial, writes a prescription for the patient, who signs a rental form, for a 35-day cycle for the unit, that is submitted to Duramed who bills the appropriate insurance company. The firm is also focuses on protecting and commercializing the cannabis patents covering liquid formulations of cannabis.
Follow-Up Questions
Can B Corp의 CEO는 누구입니까?
Mr. Marco Alfonsi은 2018부터 회사에 합류한 Can B Corp의 Chairman of the Board입니다.
CANB 주식의 가격 성능은 어떻습니까?
CANB의 현재 가격은 $0.025이며, 전 거래일에 decreased 0% 하였습니다.
Can B Corp의 주요 사업 주제나 업종은 무엇입니까?
Can B Corp은 Pharmaceuticals 업종에 속하며, 해당 부문은 Health Care입니다
Can B Corp의 시가총액은 얼마입니까?
Can B Corp의 현재 시가총액은 $1.9M입니다
Can B Corp는 매수, 매도, 아니면 보유해야 하나요?
월스트리트 분석가들에 따르면, 3명의 분석가가 Can B Corp에 대한 분석 평가를 실시했으며, 이는 2명의 강력한 매수, 4명의 매수, 1명의 보유, 0명의 매도, 그리고 2명의 강력한 매도를 포함합니다